jy9202 Veľmi pokročilý
Počet príspevkov : 542 Registration date : 18.12.2013
| Predmet: 5% increase while in the amount of cells in the G2 M phase along with a decreas St október 29, 2014 6:00 am | |
| Numerous mechanisms is usually proposed to make clear this effect, namely a rise of drug uptake by imatinib induced reduction of tumor interstitial fluid pressure and a rise of tran scapillary transport, inhibition of tumor ABT-888 angiogen esis mixed together with the antitumor result of chemotherapy, and certain intracellular events induced by the two concomitant therapeutic modalities that continue to be to get established. On the other hand, our in vivo experiments showed a higher toxicity of mixed imatinib and chemotherapy than for imat inib or chemotherapy alone, solely when each treat ments were administered concomitantly.<br><br> Various mechanisms for the toxicity of mixed therapy may be proposed, particularly pharmacokinetic interactions amongst imatinib and chemotherapeutic agents that might also explain the improve of chemotherapy induced tumor growth inhibition, as quite a few data have shown that imatinib induces cytochrome AEB071 分子量 p450 inhibition and that this inhibition decreases elimination of chemothera peutic agents this kind of as etoposide, ifosfamide, and topote can. In an effort to take a look at these pharmacokinetic interactions, we for that reason investigated the in vivo influence of imatinib on the pharmacokinetics of chemotherapy and its efficacy on two different human cancers xenografted into immunodeficient mice a SCLC and an EBV related B cell lymphoproliferation. We showed that imatinib appreciably increases the AUC of etoposide in mice by way of a decrease of its fecal excretion.<br><br> Finally, in one particular in the two xenografted designs made use of, we confirmed the imatinib induced raise of tumor development inhibition right after chemotherapy with agents this kind of as etoposide and gemcitabine. These success thus help the initi ation of even further potential phase I and II clinical trials combining etoposide primarily based chemotherapy and imatinib in cancer AG-014699 価格 individuals, such as malignant lymphoma individuals, with cautious toxicologic monitoring. Procedures In vivo experiments in immunodeficient mice bearing human tumors Female nude or SCID mice, weighing 20 g to 30 g, six eight weeks previous, had been bred in the animal services, maintained below distinct pathogen no cost situations with artificial lighting and fed which has a common diet program and water ad libitum.<br><br> The care, housing, and handling of the mice were performed in accordance with all the recommendations of the French Ethics Committee and beneath the supervision of authorized investigators. For curative therapeutic trials, the tumor bearing mice had been randomly divided into equivalent groups of six to eight animals and mice have been taken care of at different occasions just after transplantation. Two different human tumors had been utilised the SCLC6 smaller cell lung cancer xenografted in nude mice, plus the LY 3 EBV connected human B cell lymphoma xenografted in SCID mice. STI571 was diluted in 150 µl of H2O and administered at a total dosage of 70 mg/kg each day in a single intraperitoneal injection on various days, as indi cated. Etoposide and ifosfamide have been diluted in 200 µl of 0. 9% sodium chloride and administered at a dose of 12 mg/kg and 90 mg/kg, respectively, in one particular every day intra peritoneal injection on days one to 3 of treatment. | |
|